» Articles » PMID: 18214570

The Role of Mannose-binding Lectin in Systemic Lupus Erythematosus

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2008 Jan 25
PMID 18214570
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Susceptibility to systemic lupus erythematosus (SLE) is associated with genetic, hormonal, immunological, and environmental factors. Many genes have been related with the appearance of SLE, including several loci that code different complement components and their receptors. Some genetic deficiencies of complement molecules are strongly associated with SLE, probably because these deficiencies could cause decreased clearance of apoptotic cell material. As a consequence of the apoptotic material accumulation, high levels of autoantigens can be presented inappropriately to the immune system in an inflammatory context, resulting in an imbalance on the mechanisms of immunological tolerance, immune system activation, and autoantibody production. Recent studies proposed a role to the mannose-binding lectin (MBL) in the SLE physiopathogenesis. This protein activates the complement system, and the presence of several polymorphisms at the promoter and coding regions of the MBL-2 gene determines alterations at the plasma levels of MBL. Some of these polymorphisms have been associated with SLE susceptibility, as well as with clinical and laboratory typical features of this disease, cardiovascular events, and infections. Besides, it has been described that the presence of anti-MBL autoantibodies in sera of SLE patients can influence MBL plasma levels and its functional activity.

Citing Articles

Late Onset Systemic Lupus Erythematosus - Clinical and Autoantibody Profile and its Comparison with Young Onset Systemic Lupus Erythematosus.

Bindroo M, Majid N, Ekbote G, Raval D, Negalur N, Mendiratta N Mediterr J Rheumatol. 2024; 34(4):454-459.

PMID: 38282933 PMC: 10815541. DOI: 10.31138/mjr.290723.los.


Interaction between Long Noncoding RNAs and Syncytin-1/Syncytin-2 Genes and Transcripts: How Noncoding RNAs May Affect Pregnancy in Patients with Systemic Lupus Erythematosus.

Talotta R Int J Mol Sci. 2023; 24(3).

PMID: 36768581 PMC: 9917164. DOI: 10.3390/ijms24032259.


Trends in oligomannosylation and α1,2-mannosidase expression in human cancers.

Chatterjee S, Ugonotti J, Y Lee L, Everest-Dass A, Kawahara R, Thaysen-Andersen M Oncotarget. 2021; 12(21):2188-2205.

PMID: 34676051 PMC: 8522845. DOI: 10.18632/oncotarget.28064.


Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis.

Ebrahimiyan H, Mostafaei S, Aslani S, Faezi S, Farhadi E, Jamshidi A Clin Exp Med. 2021; 22(3):427-438.

PMID: 34519938 DOI: 10.1007/s10238-021-00758-0.


Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.

Morell M, Perez-Cozar F, Maranon C Int J Mol Sci. 2021; 22(13).

PMID: 34281193 PMC: 8267641. DOI: 10.3390/ijms22137143.


References
1.
Chies J . On the haplotypic frequencies of the MBL2 gene among human populations. Lupus. 2007; 16(10):838. DOI: 10.1177/0961203307083202. View

2.
Sumiya M, Super M, Tabona P, Levinsky R, Arai T, Turner M . Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991; 337(8757):1569-70. DOI: 10.1016/0140-6736(91)93263-9. View

3.
Deapen D, Escalante A, Weinrib L, HORWITZ D, Bachman B, Roy-Burman P . A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 1992; 35(3):311-8. DOI: 10.1002/art.1780350310. View

4.
Block S, Winfield J, Lockshin M, DAngelo W, Weksler M, Fotino M . Proceedings: Twin studies in systemic lupus erythematosus (SLE). Arthritis Rheum. 1975; 18(3):285. View

5.
Bultink I, Hamann D, Seelen M, Hart M, Dijkmans B, Daha M . Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther. 2006; 8(6):R183. PMC: 1794530. DOI: 10.1186/ar2095. View